Anti-tumor agent comprising cytidine derivative and carboplatin

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 33/24 (2006.01) A61K 31/7068 (2006.01) A61P 35/00 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2719202

Provision of a novel combined therapy with ECyd, which therapy exhibits remarkable antitumor effect and gives less adverse effects. The invention provides an antitumor agent containing, in combination, 1-(3-C-ethynyl-.beta.-D-ribopentofuranosyl)cytosine or a salt thereof and carboplatin.

La présente invention concerne une nouvelle polythérapie utilisant Ecyd, qui a un effet antitumoral remarquable et a peu d'effets secondaires indésirables. L'invention concerne en particulier un agent antitumoral comprenant une combinaison de 1-(3-C-éthynyl-ß-D-ribopentofuranosyl)-cytosine ou un sel de celle-ci et de la carboplatine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anti-tumor agent comprising cytidine derivative and carboplatin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-tumor agent comprising cytidine derivative and carboplatin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-tumor agent comprising cytidine derivative and carboplatin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2086337

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.